Tag: Spark Therapeutics
Spark Therapeutics bags Luxturna EU approval for inherited retinal disease
Luxturna EU approval for inherited retinal disease : Pennsylvania-based Spark Therapeutics has bagged the European Commission’s (EC) approval for its gene therapy Luxturna (voretigene neparvovec) ... Read More
Panel recommends Luxturna FDA approval for rare form of blindness
Luxturna FDA approval news : Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics is closing in towards an FDA approval for treating blindness due ... Read More